HighCape Capital, L.P. - Dec 22, 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
Director, 10%+ Owner
Signature
/s/ Kevin L. Rakin
Stock symbol
ELUT
Transactions as of
Dec 22, 2022
Transactions value $
$0
Form type
4
Date filed
12/27/2022, 05:09 PM
Previous filing
Dec 7, 2022
Next filing
Jun 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Stock Option (Right to Buy) Award $0 +17.5K $0.00 17.5K Dec 22, 2022 Class A Common Stock 17.5K $3.80 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.
F2 Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.